Chromosomal damage and atherosclerosis. A protective effect from simvastatin

European Journal of Pharmacology

Volumn 532, Issue 3, 2006, Pages 223-229

  Pernice, Franco ^a   Floccari, Fulvio ^a   Caccamo, Chiara ^a   Belghity, Nadia ^a   Mantuano, Stefania ^a   Pacilè, Maria Elisa ^a   Romeo, Adolfo ^a   Nostro, Lorena ^a   Barillà, Antonio ^a   Crascì, Eleonora ^a   Frisina, Nicola ^a   Buemi, Michele ^a,b  

^a UNIVERSITY OF MESSINA   (Italy)

^b NONE   (Italy)

Author keywords

Atherosclerosis; Dialysis; Genomic damage; Simvastatin; Sister chromatid exchange

Indexed keywords

SIMVASTATIN;

ADULT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BIOFILTRATION; CAROTID ARTERY; CAROTID ARTERY DISEASE; CHROMOSOME DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENOME ANALYSIS; HEMODIALYSIS PATIENT; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; SISTER CHROMATID; SISTER CHROMATID EXCHANGE; STATISTICAL SIGNIFICANCE;

ATHEROSCLEROSIS; CAROTID ARTERIES; CELLS, CULTURED; CHROMOSOME ABERRATIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEMODIAFILTRATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; KIDNEY FAILURE, CHRONIC; LYMPHOCYTES; MALE; MIDDLE AGED; MITOTIC INDEX; SIMVASTATIN; SISTER CHROMATID EXCHANGE;

EID: 33644516594     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.01.003     Document Type: Article

References (47)

1. M.G. Andreassi Coronary atherosclerosis and somatic mutations: an overview of the contributive factors for oxidative DNA damage Mutat. Res. 543 2003 67 86
2. M.G. Andreassi, and N. Botto DNA damage as a new emerging risk factor in atherosclerosis Trends Cardiovasc. Med. 13 2003 270 275
3. Balicek, P., Klein, R., Hager, J. 1979. Chromosomal patterns in patients treated in chronic intermittent haemodialysis programme. Sb. Ved. Pr. Lek. Fak. Karlovy. Univ. 22,1.
4. E.P. Benditt, and J.M. Benditt Evidence for a monoclonal origin of human atherosclerotic plaques Proc. Natl. Acad. Sci. U S A 70 1973 1753 1756
5. C. Blume, D. Sabuda-Widemann, J. Pfeilschifter, J. Plum, K. Schror, B. Grabensee, and K.F. Beck Cerivastatin inhibits proliferation of interleukin-1 beta-induced rat mesangial cells by enhanced formation of nitric oxide Eur. J. Pharmacol. 6 2004 485,1 485,10
6. N. Botto, A. Rizza, M.G. Colombo, A.M. Mazzone, S. Manfredi, S. Masetti, A. Clerico, A. Biagini, and M.G. Andreassi Evidence for DNA damage in patients with coronary artery disease Mutat. Res. 27 2001 493,23 493,30
7. G. Buccianti, P. Maisonneuve, B. Ravasi, D. Cresseri, F. Locatelli, and P. Boyle Cancer among patients on renal replacement therapy: a population-based survey in Lombardy, Italy Int. J. Cancer 66 1996 591 593
8. M. Buemi, A. Allegra, M. Senatore, D. Marino, M.A. Medici, C. Aloisi, G. Di Pasquale, and F. Corica Pro-apoptotic effect of fluvastatin on human smooth muscle cells Eur. J. Pharmacol. 9 1999 370,201 370,203
9. M. Buemi, M. Senatore, F. Corica, C. Aloisi, A. Romeo, E. Cavallaro, and N. Frisina Are there potential non-lipid-lowering uses of statins in the kidney? Nephron 89 2001 363 368
10. M. Buemi, M. Senatore, F. Corica, C. Aloisi, A. Romeo, E. Cavallaro, F. Floccari, D. Tramontana, and N. Frisina Statins and progressive renal disease Med. Res. Rev. 22 2002 76 84
11. E. Carbonell, F. Peris, N. Xamena, A. Creus, and R. Marcos SCE analysis in human lymphocytes of a Spanish control population Mutat. Res. 335 1995 35 46
12. A.V. Carrano, and D.H. Moore The rationale methodology for quantifying sister-chromatid exchange in humans J.A. Heddle New Horizons in Genetic Toxicology 1982 Academic Press New York 267 304
13. A.V. Carrano, and A.T. Nacarajan Considerations for population monitoring using cytogenetic techniques Mutat. Res. 204 1988 379 406
14. R. Casalone, P. Granata, E. Minelli, P. Portentoso, A. Giudici, R. Righi, P. Castelli, A. Socrate, and B. Frigerio Cytogenetic analysis reveals clonal proliferation of smooth muscle cells in atherosclerotic plaques Hum. Genet. 87 1991 139 143
15. K. Cengiz, A.M.W. Block, D.K. Hossfeld, R. Anthone, S. Anthone, and A.A. Sandberg Sister chromatid exchange and chromosome abnormalities in uremic patients Cancer Genet. Cytogenet. 36 1988 55 67
16. D. Chapman-Shimshoni, M. Yuklea, J. Radnay, H. Shapiro, and M. Lishner Simvastatin induces apoptosis of B-CLL cells by activation of mitochondrial caspase 9 Exp. Hematol. 31 2003 779 783
17. A. Corsini, F. Pazzucconi, P. Pfister, R. Paoletti, and C.R. Sirtori Inhibitor of proliferation of arterial smooth-muscle cells by fluvastatin Lancet 7 348 1996 1584
18. A. Corsini, F. Pazzucconi, L. Arnaboldi, P. Pfister, R. Fumagalli, R. Paoletti, and C.R. Sirtori Direct effects of statins on the vascular wall J. Cardiovasc. Pharmacol. 31 1998 773 778
19. N. Djelic, and D. Djelic Enhanced sister chromatide exchanges rate in human lymphocytes exposed to 17 β-Estradiol in vitro Arch. Med. Res. 33 2002 148 151
20. L. Dou, E. Bertrand, C. Cerini, V. Faure, J. Sampol, R. Vanholder, Y. Berland, and P. Brunet The uremic solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair Kidney Int. 65 2004 442 451
21. K. Goh, and R.V.M. Cestero Chromosomal abnormalities in maintenance haemodialysis patients J. Med. 10 1979 167 174
22. M. Gomberg-Maitland, V. Fuster, Z.A. Fayad, J.J. Badimon, and R. Corti Statins and plaque stability J. Cardiovasc. Risk 10 2003 161 167
23. L.N. Johnson-Anuna, G.P. Eckert, J.H. Keller, U. Igbavboa, C. Franke, T. Fechner, M. Schubert-Zsilavecz, M. Karas, W.M. Muller, and W.G. Wood Chronic administration of statins alters multiple gene expression patterns in mouse cerebral cortex J. Pharmacol. Exp. Ther. 312 2004 786 793
24. N. Handa, M. Matsumoto, and H. Maeda Ultrasonic evaluation of early carotid atherosclerosis Stroke 21 1990 1567 1572
25. D.Z. Hillyard, A.J. Cameron, A.H. McIntyre, M.H. Hadden, H.E. Marshall, N. Johnston, and A.G. Jardine Inhibition of proliferation and signalling mechanisms in human lymphocytes by fluvastatin Clin. Exp. Pharmacol. Physiol. 29 2002 673 678
26. D.Z. Hillyard, A.J. Cameron, and K.J. McDonald Simvastatin inhibits lymphocyte function in normal subjects and patients with cardiovascular disease Atherosclerosis 175 2004 305 313
27. A. Imaeda, T. Kaneko, T. Aoki, Y. Kondo, N. Nakamura, H. Nagase, and T. Yoshikawa Antioxidative effects of fluvastatin and its metabolites against DNA damage in streptozotocin-treated mice Food Chem. Toxicol. 40 2002 1415 1422
28. A. Izzotti, C. Cartiglia, J. Lewtas, and S. De Flora Increased DNA alterations in atherosclerotic lesions of individuals lacking the GSTM1 genotype FASEB J. 15 2001 752 757
29. M. Jakobisiak, and J. Golab Potential antitumor effects of statins Int. J. Oncol. 23 2003 1055 1069
30. Z. Krivosikova, M. Dusinska, V. Spustova, K. Sebekova, P. Blazicek, A. Heidland, and R. Dzurik DNA damage of lymphocytes in experimental chronic renal failure: beneficial effects of losartan Kidney Int. 50 2001 S212 S215
31. G.M. London Cardiovascular calcification in uremic patients: clinical impact on cardiovascular function J. Am. Soc. Nephrol. 14 9 2003 S305 S309
32. S. Manfredi, S. Masetti, N. Botto, M.G. Colombo, M. Terrazzi, C. Vassalle, A. Biagini, and M.G. Andreassi P53 codon 72 polymorphism in coronary artery disease: no evidence for association with increased risk or micronucleus frequency Environ. Mol. Mutagen. 40 2002 110 115
33. M.L. Marin, R.E. Gordon, F.J. Veith, N. Tulchin, and T.F. Panetta Distribution of c-myc oncoprotein in healthy and atherosclerotic human carotid arteries J. Vasc. Surg. 18 1993 170 176 (discussion 176-177)
34. T. Ohkuma, T. Minagawa, N. Takada, M. Ohno, H. Oda, and H. Ohashi C-reactive protein, lipoprotein (a), homocysteine, and male sex contribute to carotid atherosclerosis in peritoneal dialysis patients Am. J. Kidney Dis. 42 2003 355 361
35. J.L. Parkes, R.R. Cardell, F.C. Hubbard Jr., D. Hubbard, A. Meltzer, and A. Penn Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene Am. J. Pathol. 138 1991 765 775
36. Pernice F., Floccari F., Caccamo C., Belghity N., Mantuano S., Pacilè M.E., Romeo A., Barillà A., Aloisi C., Frisina N., Buemi M., (in press). Oxidative stress, sister chromatid exchanges and apoptosis in the pathogenesis of lymphocytopenia in end stage renal disease patients. J. Nephrol.
37. S. Perry, and P. Wolff Differential Giemsa staining of sister chromatids and the study of chromatid exchanges without autoradiography Chromosoma 48 1974 341 353
38. K.E. Porter, N.A. Turner, D.J. O'Regan, A.J. Balmforth, and S.G. Ball Simvastatin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA Cardiovasc. Res. 61 2004 745 755
39. G.L. Plosker, and A.G. Wagstaff Fluvastatin- a review of its pharmacology and use in the management of hypercholesterolaemia Drugs 51 1996 433 459
40. R. Ross Atherosclerosis- an inflammatory disease N. Engl. J. Med. 14 340 1999 115 126
41. I. Spyridopoulos, J. Haendeler, C. Urbich, T.H. Brummendorf, H. Oh, M.D. Schneider, A.M. Zeiher, and S. Dimmeler Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells Circulation 9 110 2004 3136 3142
42. H. Stopper, T. Meysen, A. Bockenforde, U. Bahner, and S. Vamvakas Increased genomic damage in lymphocytes of patients before and after long term maintenance hemodialysis therapy Am. J. Kidney Dis. 34 1999 433 437
43. H. Stopper, F. Boullay, A. Heidland, J. Vienken, and U. Bahner Comet-assay analysis identifies genomic damage in lymphocytes of uremic patients Am. J. Kidney Dis. 38 2001 296 301
44. K. Thompson, and M.J. Rogers Statins prevent bisphosphonate-induced gamma, delta-T-cell proliferation and activation in vitro J. Bone Miner. Res. 19 2004 278 288
45. S. Tsiara, M. Elisaf, and D.P. Mikhailidis Early vascular benefits of statin therapy Curr. Med. Res. Opin. 19 2003 540 556
46. F.J. Van Schooten, A. Hirvonen, L.M. Maas, B.A. De mol, J.C.S. Kleinjans, D.A. Bell, and J.D. Durrer Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue FASEB J. 12 1998 1409 1417
47. M. Weis, C. Heeschen, A.J. Glassford, and J.P. Cooke Statins have biphasic effects on angiogenesis Circulation 12 105 2002 739 745